Gone are the days when liver metastases from colorectal cancers are given a death sentence when diagnosed,” declares liver surgeon Catherine Teh.

Dr. Catherine Teh

     Upbeat over the “tremendous changes” in the treatment of stage IV colorectal cancer, Dr. Teh cites raised “standards of diagnostic studies, improvement of adjuvant chemotherapeutic agents and other targeted therapies.” Besides, “aggressive treatment, such as liver resections and other invasive therapeutic options in cases of liver metastases from colorectal cancers, yields good five-year survival with a good quality of life.” She points out too that major advances have been made in the management of patients with mCRC (metastatic colorectal cancer) who have potentially resectable liver metastases.

Dr. Eugene Regala: “You don’t only try to go for survival; you try to      ensure that the patient has a very good quality of life.”

     “They represent a special population for whom cure is an achievable treatment goal.”

Back to home

Read the article in the latest edition of The Big C.